• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑胶质瘤中的 SUMOylation:一种新的治疗靶点。

SUMOylation in Glioblastoma: A Novel Therapeutic Target.

机构信息

Department of Neurosurgery, University of Alabama at Birmingham, 1060 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35223, USA.

Medical Scientist Training Program, University of Alabama at Birmingham, 1825 University Boulevard, SHEL 121, Birmingham, AL 35294, USA.

出版信息

Int J Mol Sci. 2019 Apr 15;20(8):1853. doi: 10.3390/ijms20081853.

DOI:10.3390/ijms20081853
PMID:30991648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6514907/
Abstract

Protein SUMOylation is a dynamic post-translational modification which is involved in a diverse set of physiologic processes throughout the cell. Of note, SUMOylation also plays a role in the pathobiology of a myriad of cancers, one of which is glioblastoma (GBM). Accordingly, herein, we review core aspects of SUMOylation as it relates to GBM and in so doing highlight putative methods/modalities capable of therapeutically engaging the pathway for treatment of this deadly neoplasm.

摘要

蛋白质 SUMOylation 是一种动态的翻译后修饰,它参与了细胞内各种生理过程。值得注意的是,SUMOylation 也在多种癌症的病理生物学中发挥作用,其中一种是神经胶质瘤(GBM)。因此,本文综述了 SUMOylation 与 GBM 相关的核心方面,并在此过程中强调了可能有能力通过治疗性地参与该途径来治疗这种致命肿瘤的方法/模式。

相似文献

1
SUMOylation in Glioblastoma: A Novel Therapeutic Target.脑胶质瘤中的 SUMOylation:一种新的治疗靶点。
Int J Mol Sci. 2019 Apr 15;20(8):1853. doi: 10.3390/ijms20081853.
2
Inhibition of Ubc9-Induced CRMP2 SUMOylation Disrupts Glioblastoma Cell Proliferation.抑制 Ubc9 诱导的 CRMP2 SUMOylation 破坏胶质母细胞瘤细胞增殖。
J Mol Neurosci. 2019 Nov;69(3):391-398. doi: 10.1007/s12031-019-01368-y. Epub 2019 Jul 2.
3
Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming.拓扑替康是多形性胶质母细胞瘤中 SUMOylation 的有效抑制剂,可改变细胞复制和代谢编程。
Sci Rep. 2017 Aug 7;7(1):7425. doi: 10.1038/s41598-017-07631-9.
4
STAT3 as a Therapeutic Target for Glioblastoma.STAT3 作为胶质母细胞瘤的治疗靶点。
Anticancer Agents Med Chem. 2010 Sep;10(7):512-9. doi: 10.2174/187152010793498636.
5
Emerging therapeutic targets and agents for glioblastoma therapy--part II.胶质母细胞瘤治疗的新兴治疗靶点与药物——第二部分
Anticancer Agents Med Chem. 2010 Sep;10(7):511. doi: 10.2174/187152010793498672.
6
Current Development of Glioblastoma Therapeutic Agents.胶质母细胞瘤治疗药物的最新进展。
Mol Cancer Ther. 2021 Sep;20(9):1521-1532. doi: 10.1158/1535-7163.MCT-21-0159. Epub 2021 Jun 25.
7
Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression.揭示热休克因子 1 第 K298 位 SUMOylation 对胶质母细胞瘤恶性进展的影响。
Neoplasia. 2024 Nov;57:101055. doi: 10.1016/j.neo.2024.101055. Epub 2024 Sep 10.
8
SnapShot: glioblastoma multiforme.简讯:多形性胶质母细胞瘤
Cancer Cell. 2012 May 15;21(5):710-710.e1. doi: 10.1016/j.ccr.2012.04.031.
9
Emerging therapeutic targets and agents for glioblastoma therapy - part I.胶质母细胞瘤治疗的新兴治疗靶点与药物——第一部分。
Anticancer Agents Med Chem. 2010 Jul;10(6):437. doi: 10.2174/1871520611009060437.
10
Targeting SUMOylation cascade for diabetes management.靶向SUMO化级联反应用于糖尿病管理。
Curr Drug Targets. 2014;15(12):1094-106. doi: 10.2174/1389450115666140915124747.

引用本文的文献

1
Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma.巴龙霉素靶向胶质母细胞瘤中HDAC1介导的SUMO化和IGF1R易位。
Front Pharmacol. 2024 Dec 11;15:1490878. doi: 10.3389/fphar.2024.1490878. eCollection 2024.
2
Roles of posttranslational modifications in lipid metabolism and cancer progression.翻译后修饰在脂质代谢和癌症进展中的作用。
Biomark Res. 2024 Nov 18;12(1):141. doi: 10.1186/s40364-024-00681-y.
3
SENP7 inhibits glioblastoma metastasis and invasion by dissociating SUMO2/3 binding to specific target proteins.

本文引用的文献

1
Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.侵袭性边缘神经胶质瘤干细胞对电离辐射的表型可塑性。
Cell Rep. 2019 Feb 12;26(7):1893-1905.e7. doi: 10.1016/j.celrep.2019.01.076.
2
Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds.靶向蛋白质 SUMOylation 的小分子抑制剂作为新型抗癌化合物。
Mol Pharmacol. 2018 Aug;94(2):885-894. doi: 10.1124/mol.118.112300. Epub 2018 May 21.
3
Drugging SUMOylation for neuroprotection and oncotherapy.利用SUMO化修饰进行神经保护和肿瘤治疗的药物研发
SENP7通过解离与特定靶蛋白结合的SUMO2/3来抑制胶质母细胞瘤的转移和侵袭。
Open Med (Wars). 2024 Oct 7;19(1):20241052. doi: 10.1515/med-2024-1052. eCollection 2024.
4
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis.胶质母细胞瘤间质亚型增强抗氧化防御能力,降低铁死亡敏感性。
Sci Rep. 2024 Sep 5;14(1):20770. doi: 10.1038/s41598-024-72024-8.
5
Impacts of Nutlin-3a and exercise on murine double minute 2-enriched glioma treatment.Nutlin-3a与运动对富含小鼠双微体2的胶质瘤治疗的影响
Neural Regen Res. 2025 Apr 1;20(4):1135-1152. doi: 10.4103/NRR.NRR-D-23-00875. Epub 2024 Mar 1.
6
Heat shock protein 27 deficiency promotes ferrous ion absorption and enhances acyl-Coenzyme A synthetase long-chain family member 4 stability to promote glioblastoma cell ferroptosis.热休克蛋白27缺陷促进亚铁离子吸收并增强酰基辅酶A合成酶长链家族成员4的稳定性以促进胶质母细胞瘤细胞铁死亡。
Cancer Cell Int. 2023 Jan 13;23(1):5. doi: 10.1186/s12935-023-02848-3.
7
Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics.蛋白质转录组学荟萃分析确定SUMO2是多形性胶质母细胞瘤治疗中有前景的靶点。
Cancer Cell Int. 2021 Oct 29;21(1):575. doi: 10.1186/s12935-021-02279-y.
8
Structural Characterization of the RNA-Binding Protein SERBP1 Reveals Intrinsic Disorder and Atypical RNA Binding Modes.RNA结合蛋白SERBP1的结构表征揭示了内在无序和非典型RNA结合模式。
Front Mol Biosci. 2021 Sep 24;8:744707. doi: 10.3389/fmolb.2021.744707. eCollection 2021.
9
SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma.PAF1/PD2的小泛素样修饰物(SUMO)修饰可实现与早幼粒细胞白血病(PML)的相互作用并促进胰腺导管腺癌的辐射抗性。
Mol Cell Biol. 2021 Nov 22;41(12):e0013521. doi: 10.1128/MCB.00135-21. Epub 2021 Sep 27.
10
Blockade of STAT3 Signaling Contributes to Anticancer Effect of 5-Acetyloxy-6,7,8,4'-Tetra-Methoxyflavone, a Tangeretin Derivative, on Human Glioblastoma Multiforme Cells.阻断 STAT3 信号通路有助于 5-乙酰氧基-6,7,8,4'-四甲氧基黄酮,即川陈皮素衍生物,对人胶质母细胞瘤多形性细胞的抗癌作用。
Int J Mol Sci. 2019 Jul 9;20(13):3366. doi: 10.3390/ijms20133366.
Neural Regen Res. 2018 Mar;13(3):415-416. doi: 10.4103/1673-5374.228718.
4
SUMOylation in brain ischemia: Patterns, targets, and translational implications.脑缺血中的 SUMOylation:模式、靶标和转化意义。
J Cereb Blood Flow Metab. 2018 Jan;38(1):5-16. doi: 10.1177/0271678X17742260. Epub 2017 Nov 17.
5
Quantitative high-throughput screening identifies cytoprotective molecules that enhance SUMO conjugation via the inhibition of SUMO-specific protease (SENP)2.高通量定量筛选鉴定出通过抑制 SUMO 特异性蛋白酶 (SENP)2 增强 SUMO 缀合的细胞保护分子。
FASEB J. 2018 Mar;32(3):1677-1691. doi: 10.1096/fj.201700711R. Epub 2018 Jan 3.
6
Drug discovery: Controlling protein SUMOylation.药物发现:控制蛋白质 SUMOylation。
Nat Chem Biol. 2017 Oct 18;13(11):1141-1142. doi: 10.1038/nchembio.2496.
7
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.通过使用选择性 SAH 抑制剂探索 SUMOylation 在癌细胞生物学中的作用。
Nat Chem Biol. 2017 Nov;13(11):1164-1171. doi: 10.1038/nchembio.2463. Epub 2017 Sep 11.
8
Glioblastoma targeted therapy: updated approaches from recent biological insights.胶质母细胞瘤靶向治疗:基于近期生物学见解的更新方法。
Ann Oncol. 2017 Jul 1;28(7):1457-1472. doi: 10.1093/annonc/mdx106.
9
Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming.拓扑替康是多形性胶质母细胞瘤中 SUMOylation 的有效抑制剂,可改变细胞复制和代谢编程。
Sci Rep. 2017 Aug 7;7(1):7425. doi: 10.1038/s41598-017-07631-9.
10
SUMO-4: A novel functional candidate in the human placental protein SUMOylation machinery.SUMO-4:人类胎盘蛋白SUMO化机制中的一个新型功能候选物。
PLoS One. 2017 May 17;12(5):e0178056. doi: 10.1371/journal.pone.0178056. eCollection 2017.